Clinical Outcomes Of Presbyopia Correction With Presbylasik: A Systematic Review
Published 2022 - 40th Congress of the ESCRS
Reference: PO509 | Type: ESCRS 2022 - Posters | DOI: 10.82333/3qm8-4w85
Authors: Ainhoa Molina-Martín* 1 , Joaquín Fernández 2 , Carlos Rocha-de-Lossada 3 , Manuel Rodríguez-Vallejo 2 , David Pablo Piñero-Llorens 4
1Optics, Pharmacology and Anatomy,University of Alicante,San Vicente del Raspeig,Spain, 2Department of Ophthalmology (Qvision),VITHAS Hospital,Almería,Spain, 3Department of Ophthalmology,Hospital Virgen de las Nieves,Granada,Spain;Department of Ophthalmology (Qvision),VITHAS Hospital,Almería,Spain, 4Optics, Pharmacology and Anatomy,University of Alicante,San Vicente del Raspeig,Spain;Department of Ophthalmology (IMQO-Oftalmar) ,Vithas Medimar International Hospital,Alicante,Spain
Purpose
Setting
Methods
A total of 42 articles were initially identified, but after applying the selection criteria and an additional manual search a total of 15 articles were finally included: 2 non-randomized controlled clinical trials (NRCT) and 13 case series studies. Quality assessment of NRCTs and case series was performed with the ROBINS-I and the 20-criterion quality appraisal checklist defined by Moga et al, respectively.
Results
For NRCT, the risk of bias was moderate in one study and serious in the other NRCT, being the main sources of risk, the domains related to confounding, selection of participants and measurement of outcomes. For case series studies, the main source of risk of bias was subjects not entering the study at the same point of the conditions (different levels of presbyopia). Likewise, a significant level of uncertainty was detected for a large proportion of case series for the following items: consecutive recruitment of patients, blinding of outcome assessors to the intervention that the patient received, and conclusions of the study not supported by the results.
Conclusions